明源雲(00909.HK)授出合共264.3萬份受限制股份單位
格隆匯10月29日丨明源雲(00909.HK)公佈,於2021年10月29日,董事會議決根據股權激勵計劃向為集團僱員的承授人授予合共264.3萬份受限制股份單位。股權激勵計劃旨在讓集團向獲選參與者授予獎勵,作為彼等對集團所作貢獻的激勵或回報,特別是(i)鼓勵彼等提升表現及效率,令本集團受益;(ii)吸引及挽留其貢獻對或將對集團有利的參與者;及(iii)鼓勵彼等加強團隊成員合作及溝通,促進集團發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.